Diagnosis and Treatment of Obesity Hypoventilation Syndrome (OHS)
Obesity Hypoventilation Syndrome is diagnosed by the triad of BMI ≥30 kg/m², daytime hypercapnia (PaCO₂ ≥45 mmHg), and sleep-disordered breathing, after excluding other causes of hypoventilation. 1
Diagnostic Criteria
Essential Diagnostic Elements
- BMI ≥30 kg/m²
- Daytime hypercapnia (arterial PaCO₂ ≥45 mmHg)
- Sleep-disordered breathing
- Exclusion of other causes of alveolar hypoventilation
Diagnostic Algorithm
Initial Screening:
Confirmatory Testing:
- Arterial blood gas analysis to confirm daytime hypercapnia
- Polysomnography to characterize sleep-disordered breathing pattern
- Pulmonary function tests (typically show restrictive pattern with normal FEV₁/FVC ratio) 1
Phenotypic Classification:
- ~90% of OHS patients have concomitant obstructive sleep apnea (OSA)
- ~70% have severe OSA (AHI >30 events/hour)
- ~10% have non-OSA hypoventilation during sleep 1
Treatment Options
First-Line Treatment Based on Phenotype
OHS with Severe OSA (70% of cases):
OHS without Severe OSA:
- Non-invasive ventilation (NIV) is preferred 1
Management Algorithm for Different Clinical Scenarios
Stable Ambulatory Patients:
- Initiate positive airway pressure (PAP) therapy 2
- For severe OSA: CPAP
- For hypoventilation without severe OSA: Consider NIV
Hospitalized Patients with Respiratory Failure:
Weight Management (Essential Component):
Clinical Pearls and Pitfalls
- Common Pitfall: OHS is frequently misdiagnosed as COPD or heart failure 3
- Warning Sign: OHS patients have higher risk of pulmonary hypertension, heart failure, and increased mortality compared to eucapnic obese patients 1, 4
- Screening Tip: Serum bicarbonate >27 mmol/L in an obese patient with sleep-disordered breathing should raise suspicion for OHS 1
- Treatment Caution: Some patients may have persistent hypercapnia despite CPAP compliance; these patients may need to be switched to NIV 5
Follow-up Care
- Timely follow-up with sleep study and PAP titration after hospital discharge
- Regular monitoring of arterial blood gases or serum bicarbonate to assess ventilatory status
- Ongoing weight management support
- Assessment and management of cardiovascular comorbidities 1
By following this structured approach to diagnosis and treatment, clinicians can improve early recognition of OHS and implement effective treatment strategies to reduce morbidity and mortality in this high-risk population.